We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action spe... Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. Show more
HARMONY BIOSCIENCES HIGHLIGHTS NEW DATA, ROBUST LATE-STAGE PIPELINE WITH NEAR-TERM VALUE CREATION OPPORTUNITIES AND ITS BOLD NEW VISION AT INVESTOR DAY BP1.15205 Data Indicates Potential...
HARMONY BIOSCIENCES TO HOST FIRST INVESTOR DAY ON OCTOBER 1, 2024 Company leadership and key opinion leaders to share new data and provide late-stage pipeline updates PR Newswire PLYMOUTH...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.41 | -6.34544497104 | 37.98 | 40.6 | 35.57 | 566893 | 39.25718381 | CS |
4 | -0.49 | -1.35884636717 | 36.06 | 40.6 | 35.17 | 505756 | 38.41948561 | CS |
12 | 0.83 | 2.38917674151 | 34.74 | 40.6 | 29.88 | 395180 | 35.90620418 | CS |
26 | 3.07 | 9.44615384615 | 32.5 | 40.6 | 28.14 | 395900 | 32.92847206 | CS |
52 | 2.86 | 8.74350351574 | 32.71 | 40.6 | 18.6112 | 479872 | 30.15716993 | CS |
156 | -2.87 | -7.46618106139 | 38.44 | 62.085 | 18.6112 | 531337 | 38.71052484 | CS |
260 | -0.93 | -2.54794520548 | 36.5 | 62.085 | 18.6112 | 448222 | 38.10819232 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions